Science
Jose Fernando Moura: Germline EGFR T790M Linked to a 25-Fold Higher Lung Cancer Risk
Jose Fernando Moura/X

Jose Fernando Moura: Germline EGFR T790M Linked to a 25-Fold Higher Lung Cancer Risk

Jose Fernando Moura, Clinical Oncologist at Hospital Israelita Albert Einstein, shared on X:

“Germline EGFR T790M mutation and lung cancer risk 25x more and higher than cigarette ”

Title: Germline EGFR T790M Mutation and Lung Cancer Risk

Authors: Jaclyn LoPiccolo, Steven Micheletti, Jing Shi, Wei Wang, Shubham Saini, Keng-Han Lin, Wanwan Xu, Pierre Fontanillas, 23andMe Research Team, Diane R. Koeller, Helen Yatzus, Victoria G. Williamson, Jose A. Avila, Raphael B. Liautaud, Noah D. Fields, Allison Harper, Virginia Kotait, Ericka Izzo, Andrew Ciupek, Courtney A. Granville, Ryan L. Collins, Judy E. Garber, David C. Christiani, Stella Aslibekyan, Julie M. Granka, Alexander Gusev, Pasi A. Jänne

Read The Full Article.

You can also read: Beyond Pathological Stage: Multi-Omic Profiling Refines Recurrence Risk in Resected EGFR-Mutant Lung Adenocarcinoma

Jose Fernando Moura: Germline EGFR T790M Linked to a 25-Fold Higher Lung Cancer Risk

 

 

Alexander Gusev Allison Harper Andrew Ciupek cancer Courtney A. Granville David C. Christiani Diane R Koeller EGFR Ericka Izzo genetic risk Germline EGFR T790M Helen Yatzus Jaclyn LoPiccolo Jing Shi Jose A Avila Jose Fernando Moura Judy E. Garber Julie M. Granka Keng-Han Lin lung cancer risk never smokers Noah D. Fields OncoDaily Oncology Best related topic link: EGFR Pasi A. Jänne Pierre Fontanillas Raphael B. Liautaud research team Ryan L Collins Science Shubham Saini Stella Aslibekyan Steven Micheletti Victoria G Williamson Virginia Kotait Wanwan Xu Wei Wang